Potential contribution of a novel tax epitope-specific CD4+ T cells to graft-versus-tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation

Journal of Immunology

Volumn 190, Issue 8, 2013, Pages 4382-4392

  Tamai, Yotaro ^a   Hasegawa, Atsuhiko ^a   Takamori, Ayako ^a   Sasada, Amane ^a   Tanosaki, Ryuji ^b   Choi, Ilseung ^c   Utsunomiya, Atae ^d   Maeda, Yasuhiro ^e   Yamano, Yoshihisa ^f   Eto, Tetsuya ^g   Koh, Ki Ryang ^h   Nakamae, Hirohisa ^h   Suehiro, Youko ^c   Kato, Koji ⁱ   Takemoto, Shigeki ^j   Okamura, Jun ^c   Uike, Naokuni ^c   Kannagi, Mari ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c NATIONAL KYUSHU CANCER CENTER   (Japan)

^d IMAMURA BUN IN HOSPITAL   (Japan)

^e KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f ST MARIANNA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g HAMANOMACHI HOSPITAL   (Japan)

^h OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j NATIONAL HOSPITAL ORGANIZATION KUMAMOTO MEDICAL CENTER   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA DRB1 ANTIGEN; TAX 155 167 EPITOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN DETECTION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL STIMULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT VERSUS LEUKEMIA EFFECT; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; T CELL LEUKEMIA;

AGED; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; FEMALE; GENE PRODUCTS, TAX; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS;

EID: 84875992313     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202971     Document Type: Article

References (50)

1. Hinuma, Y., K. Nagata, M. Hanaoka, M. Nakai, T. Matsumoto, K. I. Kinoshita, S. Shirakawa, and I. Miyoshi. 1981. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. USA 78: 6476-6480.
2. Poiesz, B. J., F. W. Ruscetti, A. F. Gazdar, P. A. Bunn, J. D. Minna, and R. C. Gallo. 1980. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA 77: 7415-7419.
3. de Thé, G., and R. Bomford. 1993. An HTLV-I vaccine: why, how, for whom? AIDS Res. Hum. Retroviruses 9: 381-386.
4. Uchiyama, T. 1997. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu. Rev. Immunol. 15: 15-37.
5. Tsukasaki, K., T. Maeda, K. Arimura, J. Taguchi, T. Fukushima, Y. Miyazaki, Y. Moriuchi, K. Kuriyama, Y. Yamada, and M. Tomonaga. 1999. Poor outcome of autologous stem cell transplantation for adult T cell leukemia/lymphoma: a case report and review of the literature. Bone Marrow Transplant. 23: 87-89.
6. Utsunomiya, A., Y. Miyazaki, Y. Takatsuka, S. Hanada, K. Uozumi, S. Yashiki, M. Tara, F. Kawano, Y. Saburi, H. Kikuchi, et al. 2001. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 27: 15-20.
7. Tanosaki, R., N. Uike, A. Utsunomiya, Y. Saburi, M. Masuda, M. Tomonaga, T. Eto, M. Hidaka, M. Harada, I. Choi, et al. 2008. Allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning for adult T cell leukemia/lymphoma: impact of antithymocyte globulin on clinical outcome. Biol. Blood Marrow Transplant. 14: 702-708.
8. Choi, I., R. Tanosaki, N. Uike, A. Utsunomiya, M. Tomonaga, M. Harada, T. Yamanaka, M. Kannagi, and J. Okamura. 2011. Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials. Bone Marrow Transplant. 46: 116-118.
9. Okamura, J., A. Utsunomiya, R. Tanosaki, N. Uike, S. Sonoda, M. Kannagi, M. Tomonaga, M. Harada, N. Kimura, M. Masuda, et al. 2005. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood 105: 4143-4145.
10. Harashima, N., K. Kurihara, A. Utsunomiya, R. Tanosaki, S. Hanabuchi, M. Masuda, T. Ohashi, F. Fukui, A. Hasegawa, T. Masuda, et al. 2004. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation. Cancer Res. 64: 391-399.
11. + cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 348: 245-248.
12. + cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 3: 761-767.
13. Shimizu, Y., A. Takamori, A. Utsunomiya, M. Kurimura, Y. Yamano, M. Hishizawa, A. Hasegawa, F. Kondo, K. Kurihara, N. Harashima, et al. 2009. Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages. Cancer Sci. 100: 481-489.
14. + T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers. Retrovirology 8: 100.
15. + T cells. J. Exp. Med. 184: 863-871.
16. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302: 659-662.
17. Kalams, S. A., S. P. Buchbinder, E. S. Rosenberg, J. M. Billingsley, D. S. Colbert, N. G. Jones, A. K. Shea, A. K. Trocha, and B. D. Walker. 1999. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J. Virol. 73: 6715-6720.
18. + cytotoxic T-cell responses during chronic viral infection. J. Virol. 68: 8056-8063.
19. Smyk-Pearson, S., I. A. Tester, J. Klarquist, B. E. Palmer, J. M. Pawlotsky, L. Golden-Mason, and H. R. Rosen. 2008. Spontaneous recovery in acute human hepatitis C virus infection: functional T-cell thresholds and relative importance of CD4 help. J. Virol. 82: 1827-1837.
20. +, human T lymphotropic virus type-1-specific cytotoxic T lymphocytes from patients with HAM/TSP: recognition of an immunogenic region of the gp46 envelope glycoprotein of human T lymphotropic virus type-1. J. Immunol. 146: 1155-1162.
21. *0101. Clin. Exp. Immunol. 111: 278-285.
22. + helper T lymphocytes. Clin. Cancer Res. 12: 3814-3822.
23. Yamano, Y., B. Kitze, S. Yashiki, K. Usuku, T. Fujiyoshi, T. Kaminagayoshi, K. Unoki, S. Izumo, M. Osame, and S. Sonoda. 1997. Preferential recognition of synthetic peptides from HTLV-I gp21 envelope protein by HLA-DRB1 alleles associated with HAM/TSP (HTLV-I-associated myelopathy/tropical spastic paraparesis). J. Neuroimmunol. 76: 50-60.
24. + T cells: immunodominance hierarchy and preferential infection with HTLV-I. J. Immunol. 172: 1735-1743.
25. + cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood 111: 5047-5053.
26. Satou, Y., J. Yasunaga, M. Yoshida, and M. Matsuoka. 2006. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells. Proc. Natl. Acad. Sci. USA 103: 720-725.
27. Sugata, K., Y. Satou, J. Yasunaga, H. Hara, K. Ohshima, A. Utsunomiya, M. Mitsuyama, and M. Matsuoka. 2012. HTLV-1 bZIP factor impairs cellmediated immunity by suppressing production of Th1 cytokines. Blood 119: 434-444.
28. Iwasaki, Y., Y. Ohara, I. Kobayashi, and S. Akizuki. 1992. Infiltration of helper/inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection. Am. J. Pathol. 140: 1003-1008.
29. Umehara, F., S. Izumo, M. Nakagawa, A. T. Ronquillo, K. Takahashi, K. Matsumuro, E. Sato, and M. Osame. 1993. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 52: 424-430.
30. Umehara, F., S. Izumo, A. T. Ronquillo, K. Matsumuro, E. Sato, and M. Osame. 1994. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 53: 72-77.
31. Kurihara, K., Y. Shimizu, A. Takamori, N. Harashima, M. Noji, T. Masuda, A. Utsunomiya, J. Okamura, and M. Kannagi. 2006. Human T-cell leukemia virus type-I (HTLV-I)-specific T-cell responses detected using three-divided glutathione-S-transferase (GST)-Tax fusion proteins. J. Immunol. Methods 313: 61-73.
32. *1101-restricted tax epitopes recognized by cytotoxic T lymphocytes in an adult T-cell leukemia patient after hematopoietic stem cell transplantation. J. Virol. 79: 10088-10092.
33. Rammensee, H. G., T. Friede, and S. Stevanoviíc. 1995. MHC ligands and peptide motifs: first listing. Immunogenetics 41: 178-228.
34. + T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 95: 1386-1392.
35. Richardson, J. H., A. J. Edwards, J. K. Cruickshank, P. Rudge, and A. G. Dalgleish. 1990. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 64: 5682-5687.
36. + T cells. Blood 98: 1506-1511.
37. Elovaara, I., S. Koenig, A. Y. Brewah, R. M. Woods, T. Lehky, and S. Jacobson. 1993. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease. J. Exp. Med. 177: 1567-1573.
38. Kannagi, M., H. Shida, H. Igarashi, K. Kuruma, H. Murai, Y. Aono, I. Maruyama, M. Osame, T. Hattori, H. Inoko, et al. 1992. Target epitope in the Tax protein of human T-cell leukemia virus type I recognized by class I major histocompatibility complex-restricted cytotoxic T cells. J. Virol. 66: 2928-2933.
39. Pique, C., A. Ureta-Vidal, A. Gessain, B. Chancerel, O. Gout, R. Tamouza, F. Agis, and M. C. Dokhélar. 2000. Evidence for the chronic in vivo production of human T cell leukemia virus type I Rof and Tof proteins from cytotoxic T lymphocytes directed against viral peptides. J. Exp. Med. 191: 567-572.
40. *0201 transgenic mice: implications for HTLV-1 vaccine design. Vaccine 21: 2767-2781.
41. Vollers, S. S., and L. J. Stern. 2008. Class II major histocompatibility complex tetramer staining: progress, problems, and prospects. Immunology 123: 305-313.
42. + T cell responses. J. Exp. Med. 208: 81-90.
43. *0201 are influenced by epitope mutation. J. Exp. Med. 185: 1423-1433.
44. Nowak, M. A., R. M. May, R. E. Phillips, S. Rowland-Jones, D. G. Lalloo, S. McAdam, P. Klenerman, B. Köppe, K. Sigmund, C. R. Bangham, et al. 1995. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 375: 606-611.
45. Goulder, P. J., M. A. Altfeld, E. S. Rosenberg, T. Nguyen, Y. Tang, R. L. Eldridge, M. M. Addo, S. He, J. S. Mukherjee, M. N. Phillips, et al. 2001. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 193: 181-194.
46. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927.
47. Jeffery, K. J., K. Usuku, S. E. Hall, W. Matsumoto, G. P. Taylor, J. Procter, M. Bunce, G. S. Ogg, K. I. Welsh, J. N. Weber, et al. 1999. HLA alleles de- termine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy. Proc. Natl. Acad. Sci. USA 96: 3848-3853.
48. Sabouri, A. H., M. Saito, K. Usuku, S. N. Bajestan, M. Mahmoudi, M. Forughipour, Z. Sabouri, Z. Abbaspour, M. E. Goharjoo, E. Khayami, et al. 2005. Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals. J. Gen. Virol. 86: 773-781.
49. Kurihara, K., N. Harashima, S. Hanabuchi, M. Masuda, A. Utsunomiya, R. Tanosaki, M. Tomonaga, T. Ohashi, A. Hasegawa, T. Masuda, et al. 2005. Potential immunogenicity of adult T cell leukemia cells in vivo. Int. J. Cancer 114: 257-267.
50. Aubert, R. D., A. O. Kamphorst, S. Sarkar, V. Vezys, S. J. Ha, D. L. Barber, L. Ye, A. H. Sharpe, G. J. Freeman, and R. Ahmed. 2011. Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection. Proc. Natl. Acad. Sci. USA 108: 21182-21187.